Stock index for public health IT companies dropped nearly 10%

The stock price index of public companies in the health IT space dropped during the first half of 2014 by 9.6 percent, according to a report from Health Growth Partners, an Ill.-based firm.

The decline is a significant change, as in during 2012 and 2013, the stock index had risen 23.2 percent and 53.2 percent, respectively.

For the report, the researchers analyzed the stock index of 23 health IT companies. Of these, only eight companies saw an increase in their stock price: Everyday Health (36.9 percent); WebMD (25.2 percent); Health Insurance Innovation (22.9 percent); MedAssets (16.6 percent);IMS Health Holdings (11.7 percent); Imprivata (5.7 percent); Computer Programs & Systems (5 percent); and Allscripts Healthcare Solutions (4.3 percent).

The companies with the worst stock price performance included Castlight, which decreased by 61.8 percent and Covisint, which fell 61.4 percent.

Read the report here.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.